THE YPF REVERSAL — PART II: How Burford Capital Lost a $16.1 Billion Judgment and Still Made Money

Summary of Part I - From My LinkedIn Post Tthree Days Ago

Over the weekend, the day after the Second Circuit handed down its decision, I published an analysis of the ruling and what it means for litigation funding, sovereign litigation, and cross-border investor protections. For those who missed it, or who are arriving at this piece first, the key points from Part I were as follows:

• The Second Circuit reversed the $16.1 billion judgment in a 2-1 decision. The majority held that while Argentina undeniably violated YPF’s bylaws, the shareholders’ breach-of-contract claims were not cognizable under Argentine civil and public law governing expropriation. Judge Cabranes dissented and would have affirmed in full.

• The court’s own opinion confirmed the strength of the underlying facts. The majority acknowledged that Argentina touted its tender offer commitment to attract U.S. investors, likely could not have raised $1.1 billion from NYSE-listed ADRs without those protections, and committed a “knowing and flagrant violation” of its promises.

• The case is not over. En banc rehearing, Supreme Court review, and bilateral investment treaty arbitration before ICSID all remain live pathways. Burford has disclosed that King & Spalding has long been engaged on the arbitration track, and Argentina has a well-documented history of adverse investment arbitration outcomes.

• The “casino” rhetoric is wrong. Litigation funding enabled minority shareholders who had been stripped of their investment by sovereign action to pursue legitimate claims they could not have funded on their own. The reversal does not change the legitimacy of the claim or the value of the funding that made its pursuit possible.

• The real concern transcends litigation funding. When commitments embedded in SEC-filed prospectuses and corporate bylaws can be overridden by the domestic law of the sovereign that made them, it creates uncertainty for any investor in emerging market securities listed on U.S. exchanges.

The Second Circuit opinion is available here.

Why Part II?

Since publishing that piece, I have received a significant number of questions and inquiries—from litigation funders, institutional investors, patent enforcement clients, and fellow practitioners—all converging on a single theme: What does this actually mean for Burford’s bottom line? Did they lose money on this?

The answer is more nuanced than the headlines suggest, and it reveals something important about the financial architecture of modern litigation finance. Burford’s stock dropped 47%. The market wiped out hundreds of millions in equity value. Analysts are writing down the YPF asset to zero. All of that is true. But when you trace the actual cash flows—what Burford put in and what it took out—a different picture emerges. Through a disciplined secondary market strategy executed years before the reversal, Burford had already extracted multiples of its original investment in cash.

This Part II is a deep dive into those economics. It explains how Burford structured and de-risked its YPF position, why the firm likely remains cash-positive on the investment despite losing the largest judgment in litigation finance history, and what that means for how the industry should think about risk management in high-value sovereign claims.

The short version: Burford sold 38.75% of its Petersen entitlement to institutional investors for $236 million in cash between 2016 and 2019—years before trial, and roughly five times its total invested capital at the time. The reversal eliminates the residual upside on Burford’s retained interest. It does not eliminate the cash that has already been collected. This is not a story about a funder who bet the farm and lost. It is a story about a funder who harvested returns along the way, transferred risk to willing institutional buyers, and retained optionality that may still have value through international arbitration. Whether you view that as vindication of the model or an indictment of it says more about your priors than about the facts.

I. What Burford Bought and What It Paid

The financial story begins in the wreckage of Petersen Energía’s insolvency. After Argentina’s expropriation killed YPF’s dividend payments, Petersen—which had financed its 25% stake with leveraged loans secured against the shares—defaulted within weeks and entered insolvency proceedings in Spain. As part of its bankruptcy liquidation, Petersen sold its litigation claims against Argentina to Prospect Investments LLC, a wholly owned subsidiary of Burford Capital, for approximately €15 million—roughly $18 million at prevailing exchange rates.

The deal structure was straightforward: Burford would receive 70% of any recovery obtained in the Petersen case. Petersen’s insolvency estate would receive 30%. Burford bore all case costs.

In 2018, Burford expanded its position. Eton Park Capital Management, a New York hedge fund that held about 3% of YPF’s shares, was in the process of dissolving. Burford paid a $21 million advance in exchange for the right to receive 70% of Eton Park’s recovery, less fees and expenses. The net combined impact of the funding agreement and a related monetization transaction gave Burford an expected entitlement to approximately 73% of any Eton Park proceeds.

Over the following years, Burford funded what became one of the most complex and expensive pieces of litigation in the history of the Southern District of New York. Multiple law firms, including Clement & Murphy, Kellogg Hansen, and King & Spalding. Competing expert reports on Argentine civil, commercial, and public law. An interlocutory appeal to the Second Circuit. Summary judgment briefing. A bench trial on damages. Post-judgment enforcement proceedings. And then the merits appeal that produced the reversal.

All told, Burford’s total deployed capital on YPF-related assets—the Petersen acquisition, the Eton Park transaction, and over a decade of case costs—reached approximately $185 million. After accounting for third-party interests that Burford had sold (discussed below), its net exposure was approximately $108 million.

II. The Secondary Market Strategy

This is the part of the story that did not make the headlines, and it is the part that matters most.

Beginning in late 2016—years before the case went to trial, and seven years before the reversal—Burford began selling participation interests in its Petersen entitlement to institutional investors on the secondary market. These were not fire sales by a nervous funder looking to dump exposure. They were methodical, organized placements to sophisticated buyers who conducted their own diligence on the merits of the Argentina litigation, the enforceability of a potential judgment against a sovereign defendant, and the binary risk profile of the claim.

The Sales Timeline

December 2016: Burford disclosed its first secondary sale—“several million dollars in participation interests.” The firm characterized the individual sales as “immaterial” but noted that the implied valuation priced its Petersen investment at more than ten times its total deployment to date, which at that point was less than $18 million. Burford described the sales as providing “multiple benefits,” including “risk management and improved capital efficiency.”

By June 2018: Burford had sold 28.75% of its Petersen entitlement to institutional investors for $136 million in cumulative cash proceeds. At this point, Burford had spent less than $50 million on its entire YPF portfolio. The secondary sales alone had returned nearly three times its total invested capital.

June 2018 (Eton Park offset): Contemporaneously with closing the Eton Park acquisition, Burford sold an additional 3.75% of its Petersen entitlement for $30 million—specifically to offset the $21 million cash outlay of the Eton Park deal and keep its total cash exposure roughly constant. This single sale implied a valuation of $800 million for Burford’s original total Petersen entitlement.

June 2019: Burford executed its most significant secondary placement as part of a $148 million institutional offering. Of that, Burford sold $100 million of its own interest; other third-party holders sold the remainder. Burford characterized this as an “orderly transaction” following an “organized marketing process” that represented approximately 15% of the total Petersen asset and involved multiple market participants.

The Final Tally

By 2019, Burford had sold 38.75% of its Petersen entitlement for a cumulative $236 million in cash. Its remaining net share of any Petersen recovery had been reduced from 70% (gross) to approximately 35% after accounting for the secondary sales, law firm entitlements, and case expenses. It retained 100% of its Eton Park entitlement, approximately 73% of any recovery.

From a total investment of less than $50 million at the time of the secondary sales, Burford realized $236 million in cash—a return of roughly 5x its deployed capital—before the case ever went to trial. It still retained substantial upside exposure through its residual Petersen and Eton Park interests, but the secondary sales had effectively eliminated Burford’s downside risk on the original investment while preserving significant optionality.

What Burford Chose Not to Sell

The strategic discipline here extends beyond what Burford sold. It retained 100% of its Eton Park entitlement throughout the litigation, concentrating its unsold exposure in the claim with the strongest nexus to U.S. markets—Eton Park was a New York-based hedge fund—and the most favorable economics (73% of recovery versus 35% of the larger Petersen claim after secondary sales). This was not indiscriminate selling. It was portfolio optimization within a single litigation asset, allocating retained exposure to the position where each marginal dollar of risk was best deployed.

Every secondary sale also served a validation function. The institutional investors who purchased Petersen participations at valuations implying an $800 million asset were not passive buyers. They conducted independent diligence on the Argentina litigation, the enforceability question, and the binary risk. Their willingness to buy at those prices provided market-based confirmation of the claim’s merit—a data point that the litigation funding industry has rarely been able to generate at this scale.

III. The Math After the Reversal

Now apply the reversal to these numbers.

Cash in: $236 million from secondary sales (2016–2019). This money was irrevocably Burford’s. It was paid by institutional investors who accepted the binary risk in exchange for a share of the potential recovery. The reversal does not claw it back.

Cash out: Approximately $185 million in total deployed capital (Petersen acquisition, Eton Park transaction, and cumulative case costs over a decade). After accounting for third-party interests, Burford’s net cash exposure was approximately $108 million.

Net position: Even on the gross $185 million figure, Burford’s $236 million in secondary receipts exceeded its total deployed capital by $51 million. On the net $108 million figure, the surplus is $128 million. By either measure, Burford is cash-positive on the YPF investment even if it never collects another dollar from the litigation.

What Burford loses is the carried interest—the residual 35% of Petersen and 73% of Eton Park that, at the peak of the $16.1 billion judgment, would have been worth billions. That unrealized gain was a cornerstone of Burford’s balance sheet valuation and its equity story. Its elimination is what drove the 47% stock decline. But lost optionality is not the same as a cash loss. Burford’s cash was already in the bank.

To put a finer point on it: had the $16.1 billion judgment been collected in full, Burford’s 35% net share of the Petersen recovery alone would have been worth approximately $2.6 billion (35% of $7.5 billion in damages), plus its proportional share of $6.9 billion in prejudgment interest. Its 73% of the Eton Park recovery would have added hundreds of millions more. The total would have been transformative for a company whose market capitalization was hovering around $1 billion before the reversal. That is the upside the market is now mourning. But mourning lost upside is fundamentally different from absorbing a cash loss. The $236 million already collected is not a mark-to-market estimate. It is money in the bank, spent, invested, or distributed years ago.

What the Secondary Buyers Lost

The more painful story belongs to the institutional investors who purchased 38.75% of Burford’s Petersen entitlement for $236 million. Those investors underwrote the binary risk of the Argentina litigation at implied valuations in the hundreds of millions. If the judgment had survived appeal, their returns would have been extraordinary. With the reversal, their positions face the same writedown that Burford’s retained interest faces—though the ICSID arbitration pathway means their exposure is not necessarily at zero.

This is, of course, exactly how secondary markets are supposed to work. Risk was transferred from Burford to institutional investors who were compensated for bearing it through the discount at which they purchased. Some of those investors may have purchased at valuations that assumed a high probability of collection; others may have been pricing in the optionality of a partial recovery or settlement. In either case, the risk transfer was transparent and consensual. Burford did not offload toxic assets onto unsuspecting buyers. It created a market for a litigation-linked financial instrument, and sophisticated participants chose to invest.

IV. What This Reveals About Litigation Finance as an Asset Class

In Part I, I argued that the reversal does not invalidate the litigation funding model. In this Part II, I want to go further: Burford’s management of the YPF investment is not just a case of a funder surviving a loss. It is a demonstration of financial sophistication that the industry’s critics consistently fail to understand.

A Single Asset as a Portfolio

Burford’s YPF strategy illustrates a principle that is central to sophisticated litigation finance: a single litigation asset can be managed as its own portfolio through secondary market transactions, creating multiple layers of return generation and risk mitigation. The primary investment (acquiring the claims) generated embedded optionality. The secondary sales (selling participation interests) converted a portion of that optionality into realized cash returns. The retained interest preserved upside exposure. And the continuing arbitration pathway maintains residual optionality even after the reversal.

This is not gambling. It is portfolio construction and risk management of the same caliber employed by private equity and venture capital firms managing concentrated positions. A venture capital fund that takes a company public, sells a portion of its stake in secondary offerings, and retains a residual position does not “lose” if the stock later declines—it has already locked in returns through disciplined exits. Burford did the same thing with a litigation asset.

The Maturation of Secondary Markets

The YPF investment may be the most consequential test case for the emerging secondary market in litigation assets. Burford created institutional-grade liquidity around a single claim, attracting multiple market participants across a series of organized placements over three years. The implied valuations provided real-time, market-based price discovery for a litigation-linked financial instrument—something the industry has struggled to achieve.

The reversal will test whether this market infrastructure is durable. If institutional investors treat the YPF outcome as a single loss within a diversified portfolio of litigation-linked investments—as they would treat any adverse outcome in private equity or distressed debt—the secondary market will continue to develop. If they retreat from litigation assets entirely, the industry will lose a critical tool for risk management and capital efficiency.

My expectation is the former. Sophisticated institutional investors understand binary risk. They priced it into their purchases. The fact that one outcome went against them does not invalidate the asset class any more than a single default invalidates the high-yield bond market.

Concentration Risk and Position Sizing

If there is a legitimate criticism to draw from Burford’s YPF experience, it is about concentration risk at the equity level. The YPF asset was such a dominant component of Burford’s balance sheet valuation that its reversal wiped out nearly half the company’s market capitalization in a single session. That level of concentration in a publicly traded vehicle creates the kind of binary equity risk that institutional investors find difficult to manage.

But this is a portfolio management observation, not a litigation funding criticism. Every asset class faces concentration risk. Softbank’s Vision Fund concentrated in WeWork. Sequoia concentrated in FTX. Archegos concentrated in ViacomCBS. In each case, the lesson was about position sizing and portfolio construction—not about whether venture capital, or hedge funds, or total return swaps are legitimate investment strategies. The same applies here. The question for Burford going forward is whether its equity investors will tolerate this level of single-asset concentration, not whether litigation funding works.

V. Burford’s Operating Position After the Reversal

Burford moved quickly to separate the YPF outcome from its operating business. In a statement issued on March 30, the firm disclosed more than $700 million in cash, cash equivalents, and marketable securities on hand. It noted that the YPF case had not provided any cash to Burford since 2019 and that the firm had long operated without relying on a cash contribution from the case. The firm reaffirmed its target to double its core portfolio by 2030 and stated that the reversal has no impact on its core operations or growth plans.

The GAAP write-down will be substantial—Burford expects to provide full details with its Q1 2026 results in May—but it is a non-cash event. The operational impact is the lost optionality, not a cash drain. Burford’s portfolio continues to generate over $1.2 billion in cash over rolling two-year periods, and the firm expects its total portfolio to deliver over $5 billion in cash proceeds over time.

Wedbush downgraded Burford to Neutral and cut its price target to $4.75. B. Riley slashed its target to $7.50, valuing the YPF assets at zero. The market capitalization fell to approximately $921 million. But even at these depressed levels, multiple analysts maintain Buy ratings, and Burford’s Fair Value analyses suggest significant undervaluation. The market is repricing Burford for the loss of a potential future windfall—not for deterioration in the operating business that generates cash today.

VI. The Arbitration Pathway: Why the Investment May Not Be at Zero

I discussed the remaining appellate options in Part I, so I will not repeat them here except to note that the 14-day window for seeking en banc rehearing is open and that Judge Cabranes’ dissent provides a credible foundation for further review.

What deserves additional attention is the investment treaty arbitration pathway, which Burford has now publicly committed to pursuing. Argentina is party to bilateral investment treaties with Spain (relevant to Petersen) and the United States (relevant to Eton Park). Those treaties provide for compensation upon the expropriation of investor assets or in the absence of fair and equitable treatment. Claims would likely be brought before the International Centre for Settlement of Investment Disputes (ICSID), an agency of the World Bank.

Three facts make this pathway particularly credible. First, Argentina has a well-documented history of losing investment treaty arbitrations. It has been one of the most frequently respondent states in ICSID history. Second, Burford itself has previously funded a successful bilateral investment treaty claim against Argentina, giving the firm institutional knowledge of how such proceedings work and how Argentina litigates them. Third, the extensive factual and legal record developed over a decade of U.S. litigation—including the district court’s detailed findings on liability, the parties’ expert reports on Argentine law, and the Second Circuit’s own acknowledgment that Argentina committed a “knowing and flagrant violation”—provides a substantial evidentiary foundation that could abbreviate the arbitration process.

The duration of any ICSID arbitration remains uncertain, and Burford has acknowledged it would be a multi-year process. But the existence of this pathway means that the YPF investment is not binary in the way the market is currently pricing it. There is a meaningful, if uncertain, residual value to Burford’s retained interests—and to the interests of the secondary market investors who hold the other 38.75% of the Petersen entitlement.

It is also worth noting that the ICSID pathway addresses exactly the problem the Second Circuit identified. The majority held that Argentine public law governing expropriation precludes private contract-based claims that would “impede the expropriation or its effects.” Investment treaty arbitration operates on a different legal basis entirely—it does not depend on Argentine civil codes or the General Expropriation Law. It rests on treaty obligations that Argentina assumed as a matter of international law. In a sense, the Second Circuit’s ruling, by confirming that U.S. courts are not the proper forum for these claims, may have strengthened the case for ICSID jurisdiction by demonstrating that domestic remedies are unavailable—a prerequisite for many investment treaty claims.

VII. What Argentina Won and What It Didn’t

The reversal is a tactical victory for Argentina, but it may prove pyrrhic. The Second Circuit’s majority opinion is now binding precedent confirming that Argentina’s expropriation of YPF involved a “knowing and flagrant violation” of investor protections the Republic itself created and promoted in SEC filings. That language will appear in every future bilateral investment treaty arbitration filing, every sovereign bond offering disclosure, and every risk assessment by institutional investors evaluating Argentine exposure.

Argentina avoided paying $16.1 billion, but it has paid an incalculable price in investor confidence—and the ICSID arbitration pathway means the financial reckoning may be postponed, not avoided. Moreover, the decade of funded litigation itself imposed enormous costs on Argentina: the legal fees for Sullivan & Cromwell and its team of experts, the distraction of government resources, the uncertainty around its YPF stake during enforcement proceedings, and the reputational damage to its capital markets access. None of those costs are refunded by a favorable appellate ruling.

VIII. Why This Case Is Exactly Why Litigation Funding Is Good for the Market and Good for Americans

The critics will point to the YPF reversal and say it proves that litigation funding is speculative, destabilizing, or unnecessary. They have it precisely backwards. Strip away the headlines and the stock ticker, and what this case actually demonstrates—at every stage, in every dimension—is exactly why litigation funding is needed.

Without Funding, This Case Dies in 2012

Begin with the most basic fact. When Argentina expropriated YPF and refused to conduct the required tender offer, Petersen Energía—the largest minority shareholder, holding 25% of YPF’s Class D shares—collapsed. Its leveraged acquisition had been financed with debt secured against its YPF shares, serviced by YPF’s dividend payments. Argentina’s seizure of the company killed the dividends. Petersen defaulted within weeks. Its lenders foreclosed on its YPF ADRs. It entered insolvency proceedings in Spain two months later.

An insolvent Spanish entity, facing what the district court found to be a “well-founded fear of prosecution” if it brought suit in Argentina, holding breach of contract claims against a sovereign nation represented by Sullivan & Cromwell—that entity had precisely zero ability to pursue this litigation on its own. No law firm would take a decade-long sovereign dispute against the Argentine Republic on pure contingency. The claims were meritorious—the Second Circuit itself confirmed that Argentina committed a “knowing and flagrant violation” of its bylaws—but meritorious claims are worthless if no one can afford to litigate them. Without Burford’s €15 million acquisition of the claims and its willingness to fund what became $185 million in total case costs, this case dies a quiet death in a Spanish insolvency proceeding in 2012. Argentina expropriates private property, mocks its own bylaws on the floor of the Argentine Senate, and faces no legal accountability of any kind. That is not a hypothetical. That is what happens in a world without litigation funding.

The Loss Was Shifted from Vulnerable Investors to a Professional Risk-Bearer

Consider who bears the loss here. In the absence of litigation funding, the full, permanent, unrecoverable loss of the expropriation falls on Petersen’s shareholders and creditors—a family-owned Argentine business entity and the financial institutions that extended it credit. These are not parties with the resources or the risk tolerance to absorb a multi-billion-dollar sovereign taking and then litigate against the Republic of Argentina for a decade in U.S. federal court. They are, in the most literal sense, the smaller investors that securities regulations and corporate bylaw protections are designed to protect.

What Burford did was assume that loss. It paid €15 million to acquire claims that the insolvency estate could not pursue, and it committed to funding the litigation at its own risk. If the case failed—as the Second Circuit has now held on the merits—the loss falls on Burford and the institutional investors who purchased secondary participations. It does not fall on Petersen’s creditors. It does not fall on the family that built and lost a business because a sovereign government broke its word. The risk was transferred from parties who could not bear it to a party that priced it, managed it, and structured its exposure to survive it.

This is not some incidental feature of the litigation funding model. It is the core value proposition. Litigation funding exists to do precisely what happened here: take risks that are too large, too complex, and too long-duration for individual claimants to bear, and transfer them to professional risk-bearers with diversified portfolios and the capital to sustain protracted fights. The fact that this particular fight ended in an appellate reversal does not mean the risk transfer was a mistake. It means the risk transfer worked exactly as designed. The party best equipped to absorb the loss is absorbing the loss. The parties least equipped to absorb it were protected from it years ago.

Even Eton Park Needed Funding

The risk-shifting function is even more stark in the Eton Park context. Eton Park was not an insolvent family business. It was a New York hedge fund with sophisticated investors and experienced counsel. And yet when the time came to pursue decade-long litigation against a sovereign defendant, Eton Park was dissolving. It lacked the organizational continuity to see the case through. Without Burford stepping in with a $21 million advance and a commitment to fund the litigation to conclusion, Eton Park’s claims—held by a New York entity, arising from securities purchased on the NYSE, governed in part by SEC-filed prospectus disclosures—would have evaporated in a fund wind-down. If even a hedge fund cannot sustain this kind of litigation without a funder, it should be self-evident that ordinary minority shareholders cannot either.

A Decade of Litigation That Only Funding Could Sustain

The sheer duration and complexity of this case is itself an argument for litigation funding. From filing in 2015 to the Second Circuit’s reversal in 2026, this litigation spanned eleven years. It survived FSIA challenges, two rounds of forum non conveniens motions, an interlocutory appeal to the Second Circuit, cross-motions for summary judgment involving competing expert reports on Argentine civil, commercial, and public expropriation law, a bench trial on damages, post-judgment enforcement proceedings including an order transferring Argentina’s YPF shares, and finally the merits appeal that produced the reversal. The case required engagement of Paul Clement, Kellogg Hansen, King & Spalding, and Randy Mastro—some of the most expensive appellate and trial counsel in the country—along with world-class experts on Argentine law, damages, and valuation.

No individual plaintiff funds that. No contingency arrangement sustains it. The carrying cost of eleven years of elite legal representation against a sovereign defendant represented by Sullivan & Cromwell is measured in the tens of millions of dollars per year. The only reason this case reached the point where a federal district judge could find liability, calculate $16.1 billion in damages, and force Argentina to begin transferring its YPF shares is that a litigation funder stood behind it with patient, committed capital.

Funding Created Accountability That Would Not Otherwise Exist

Even if the reversal stands—even if en banc rehearing is denied, certiorari is not granted, and the ICSID arbitration yields a lesser recovery or no recovery at all—the funded litigation has already produced consequences that would not exist without it.

Argentina spent a decade defending a $16.1 billion judgment. It retained Sullivan & Cromwell and a team of experts. It briefed and argued an interlocutory appeal, renewed motions to dismiss, summary judgment, a trial, and a merits appeal. It faced a post-judgment order requiring it to transfer its controlling stake in the country’s largest oil company. It endured years of international press coverage in which the words “knowing and flagrant violation” appeared in a binding federal appellate opinion describing its conduct. Its sovereign credit profile, its ability to attract foreign investment, and its standing in international capital markets were all affected by the existence and progression of this litigation.

None of that happens without a funder. Without Burford, Argentina’s expropriation of YPF is a one-week news story in 2012 that fades from memory. The bylaws are violated. The minority shareholders are wiped out. The Deputy Economy Minister’s declaration that compliance would be “stupid” stands as the final word. There is no judicial finding. There is no appellate opinion confirming the violation. There is no legal record that future investors, future tribunals, and future sovereigns can point to. Litigation funding did not just enable a lawsuit. It created a permanent record of accountability that will inform every future assessment of Argentine sovereign risk and every future investment treaty arbitration involving the Republic.

The Legal Record as a Public Good

There is a broader point here that extends beyond the interests of the parties. The decade of funded litigation produced an extraordinary legal record on questions that matter to the international investment community, to scholars of foreign sovereign immunity, and to practitioners of international arbitration. The Second Circuit’s opinion is now the leading authority on the interaction between Argentine expropriation law and private corporate bylaw protections. It addresses the cognizability of shareholder-versus-shareholder breach of contract claims under Argentine civil codes. It interprets Article 28 of Argentina’s General Expropriation Law. It applies the FSIA’s commercial activity exception to a sovereign act of expropriation. And it does so on the basis of a factual record developed over a decade of expert testimony, documentary evidence, and judicial findings.

That legal record is a public good. It exists because a litigation funder committed the capital to create it. The next set of investors who are harmed by a sovereign expropriation will litigate in the shadow of this opinion. The next set of treaty arbitrators who hear a claim against Argentina will have the benefit of the expert reports, the factual findings, and the appellate analysis that this case produced. The development of law requires cases to be brought, briefed, and decided. When the parties who have standing to bring those cases cannot afford to do so, the law does not develop. Litigation funding fills that gap.

The Full Picture

Take a step back and consider what litigation funding accomplished in this case, viewed in its totality. It rescued meritorious claims from a Spanish insolvency proceeding where they would have been extinguished for pennies. It shifted the economic risk of a decade-long sovereign dispute from vulnerable minority investors to a professional risk-bearer with a diversified portfolio. It sustained eleven years of litigation against a sovereign defendant through every procedural and substantive challenge the Republic could mount. It produced a $16.1 billion trial court judgment that forced Argentina to confront the consequences of its conduct. It created a secondary market for the litigation asset, allowing institutional investors to participate in the risk and return of the claim. It generated a binding appellate opinion that permanently documents Argentina’s “knowing and flagrant violation” of investor protections. And even after the reversal, it preserved multiple pathways for continued recovery through international arbitration.

Critics of litigation funding look at the reversal and see a funder that lost a bet. Practitioners look at the same facts and see an access-to-justice mechanism that did exactly what it was supposed to do: it enabled a fight that could not otherwise have been fought, it transferred risk to parties who could bear it, and it created legal accountability where none would have existed. The outcome of any individual case—win or lose—does not change the fundamental proposition. The litigation funding model is not validated by victories and invalidated by defeats. It is validated by the fact that, in its absence, the courthouse doors close on the people who need them most.

This case proves it.

IX. Conclusion

The question I have received most since Friday is whether the YPF reversal is a “kill shot” against Burford or against litigation funding generally. The answer to both is no.

Burford Capital acquired litigation claims from an insolvent plaintiff for €15 million. It funded a decade-long campaign against a sovereign nation that had openly violated its own bylaws. It built the legal record that produced a $16.1 billion judgment—the largest in the history of litigation finance—even if that judgment did not survive a divided appellate panel’s de novo reinterpretation of Argentine law. Along the way, it created a secondary market for its litigation asset, sold participation interests to institutional investors for $236 million, and recouped approximately five times its initial investment in cash before the case went to trial. After the reversal, it retains multiple pathways for continued recovery, including international arbitration under bilateral investment treaties where Argentina’s track record is unfavorable.

The stock market is repricing future optionality. The cash receipts are already in the bank.

For critics who see in this reversal proof that litigation funding turns courtrooms into casinos, I would pose the question I ended Part I with, but reframed: What would have happened to Petersen’s shareholders—bankrupt, facing threats of prosecution in Argentina, holding claims that no law firm would take on contingency against a sovereign defendant—if no one had funded their fight? Argentina would have expropriated their investment, mocked its own bylaws, and faced no accountability of any kind. Litigation funding did not create a casino. It created a courthouse.

And as the financial record makes clear, it also created a return.

Part I of this series is available here.

Erick Robinson is a patent litigation partner at Cherry Johnson Siegmund James, PLLC, and host of the Litigation Funding Podcast and publisher of the PatentLitigation.blog.

Disclaimer: This article is provided for informational and educational purposes only and does not constitute legal or investment advice. The views expressed are those of the author and do not necessarily reflect those of Cherry Johnson Siegmund James, PC or its clients.